Cabaletta Bio (CABA) Shares Outstanding (2018 - 2026)
Cabaletta Bio (CABA) posted quarterly Shares Outstanding (Entity) of $66.9 million for Q4 2025, up 495.89% year-over-year from $11.2 million in Q4 2024, and down 30.48% quarter-over-quarter from $96.3 million in Q3 2025.
Analysis
Cabaletta Bio (CABA) Shares Outstanding (2018 - 2026) Analysis & Trends
Cabaletta Bio's Shares Outstanding (Entity) history runs 8 years deep, the most recent figure standing at $66.9 million for Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) rose 495.89% year-over-year to $66.9 million; the TTM figure through Dec 2025 stood at $66.9 million (up 495.89% YoY), while the FY2025 annual figure was $66.9 million, up 495.89% from the prior year.
- Shares Outstanding (Entity) for Q4 2025 stood at $66.9 million, down from $96.3 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $96.3 million in Q3 2025, with the low at $507884.0 in Q2 2024.
- The 5-year median for Shares Outstanding (Entity) is $10.5 million (2024), against an average of $22.5 million.
- The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) tumbled 93.62% in 2023, then soared 12083.21% in 2025.
- Cabaletta Bio's Shares Outstanding (Entity) stood at $4.3 million in 2021, then jumped by 41.25% to $6.0 million in 2022, then soared by 35.38% to $8.1 million in 2023, then jumped by 37.96% to $11.2 million in 2024, then surged by 495.89% to $66.9 million in 2025.
- Business Quant data shows CABA's Shares Outstanding (Entity) at $66.9 million in Q4 2025, $96.3 million in Q3 2025, and $61.9 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 61.30 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 398.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 210.89 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 111.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 133.61 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 445.06 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Cabaletta Bio | 522.26 Mn | 522.26 Mn | - | 151.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 151.16 Mn |
| Dec 31, 2025 | 79.90 Mn |
| Sep 30, 2025 | 102.26 Mn |
| Jun 30, 2025 | 61.88 Mn |
| Mar 31, 2025 | 50.74 Mn |
| Dec 31, 2024 | 49.52 Mn |
| Sep 30, 2024 | 49.47 Mn |
| Jun 30, 2024 | 49.45 Mn |
| Mar 31, 2024 | 50.47 Mn |
| Dec 31, 2023 | 1.17 Mn |
| Sep 30, 2023 | 2.35 Mn |
| Jun 30, 2023 | 4.13 Mn |
| Mar 31, 2023 | 4.13 Mn |
| Dec 31, 2022 | 5.94 Mn |
| Sep 30, 2022 | 29.01 Mn |
| Jun 30, 2022 | 28.99 Mn |
| Mar 31, 2022 | 28.96 Mn |
| Dec 31, 2021 | 25.74 Mn |
| Sep 30, 2021 | 25.85 Mn |
| Jun 30, 2021 | 24.73 Mn |